methylprednisolone hemisuccinate has been researched along with Neoplasms in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grem, JL; Quinn, MG; Schuler, B; Thomas, RR | 1 |
GIGNOUX, M; POMMATAU, E; REVILLARD, JP | 1 |
Broadwater, G; Chao, NJ; Folz, RJ; Wanko, SO | 1 |
Cook, RJ | 1 |
Futatsugi, K; Kobayashi, H; Koizumi, W; Komatsu, H; Minato, K; Nakarai, I; Nukariya, N; Taira, O; Uchiyama, T; Yamaguchi, T | 1 |
Giongo, F; Lucchi, R; Popiela, T | 1 |
Della Cuna, GR; Pellegrini, A; Piazzi, M | 1 |
Ruderman, MI; Turkewitz, LJ | 1 |
1 review(s) available for methylprednisolone hemisuccinate and Neoplasms
Article | Year |
---|---|
Hypersensitivity and idiosyncratic reactions to oxaliplatin.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Cimetidine; Dexamethasone; Diphenhydramine; Drug Hypersensitivity; Dyspnea; Erythema; Female; Fever; Histamine H2 Antagonists; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Neoplasms; Organoplatinum Compounds; Oxaliplatin | 2003 |
3 trial(s) available for methylprednisolone hemisuccinate and Neoplasms
Article | Year |
---|---|
[A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasms; Vomiting | 1995 |
Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group.
Topics: Double-Blind Method; Female; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Multicenter Studies as Topic; Neoplasms; Palliative Care; Quality of Life; Randomized Controlled Trials as Topic; Terminal Care | 1989 |
Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Multicenter Studies as Topic; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic | 1989 |
4 other study(ies) available for methylprednisolone hemisuccinate and Neoplasms
Article | Year |
---|---|
[Value of methyl-6-prednisolone sodium hemisuccinate (Solumedrol) in the treatment of malignant tumors].
Topics: Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Neoplasms; Prednisolone; Sodium; Sodium, Dietary | 1962 |
Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid.
Topics: Adult; Aminocaproates; Anti-Inflammatory Agents; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Lung Diseases; Male; Methylprednisolone Hemisuccinate; Middle Aged; Neoplasms; Respiratory Insufficiency; Retrospective Studies; Time Factors | 2006 |
Interim analyses in 2 x 2 crossover trials.
Topics: Antiemetics; Antineoplastic Agents; Biometry; Clinical Trials as Topic; Cross-Over Studies; Humans; Mathematics; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Research Design | 1995 |
Current therapy of demyelinating neuropathies.
Topics: Adrenocorticotropic Hormone; Adult; Charcot-Marie-Tooth Disease; Child; Chronic Disease; Combined Modality Therapy; Demyelinating Diseases; Humans; Immunosuppressive Agents; Methylprednisolone Hemisuccinate; Neoplasms; Nervous System Diseases; Paraproteinemias; Plasmapheresis; Polyradiculoneuropathy; Prednisolone; Prednisone; Respiration, Artificial | 1985 |